Speakers

Assaf Oron

Assaf Oron

Chief Business Officer

BiomX

Gerard Honig

Director, Research Innovation

Crohn’s & Colitis Foundation

Sonia Timberlake

Sonia Timberlake

VP Research

Finch Therapeutics

Stewart Campbell

CEO

Axial Therapeutics

Ken Blount

Ken Blount

VP Microbiome Research & CSO

Rebiotix, a Ferring Company

Mark Smith

CEO

Finch Therapeutics

Morten Isaksen

CEO

Bio-Me AS

Travis Whitfill

Co-Founder, Executive Director of Advanced Technology Chair, Scientific Advisory Board

Azitra

Brian Klein

CEO

BrickBuilt Therapeutics

Paul Carlson

Principal Investigator

FDA

Sean Gibbons

Assistant Professor

Institute Systems Biology

Yvonne Nyavor

Principal Scientist, Microbiome

Boston Analytical

Bharat Dixit

VP, Biopharmaceutical Development & Manufacturing

Artugen Therapeutics

Fyza Shaikh

Instructor

John Hopkins Medical Center

Louis Cohen

Assistant Professor

Icahn School of Medicine, Mount Sinai

David Ege

CTO

Seres Therapeutics

Denise Kelly

Investment Advisor

Seventure Partners

Jeanette Mucha

CEO

SciBac

Nikole Kimes

Founder & CEO

Siolta Therapeutics

Caitlin SL Parello

Caitlin SL Parello

Senior Scientist II, Associate Director of Research Operations

Biomodels

Felix Faupel

Felix Faupel

Chief Commerical Officer

BacThera

Mark Charbonneau

Head, Quantitative Biology

Synlogic

Peter McCaffrey

CRO

VastBiome

Antonio DiGiandomenico

Director of Microbiome Discovery

AstraZeneca

Dirk Gevers

Global Head Janssen Human Microbiome Institute

Janssen Research & Development

Jessica Schneider

Director of Gastroenterology

Takeda

Xin Guo

Principle Scientist

Merck

John Hambor

Director, Research Beyond Boarders

Boehringer Ingleheim

Nancy Dubois

Associate Director, Local Safety Officer US Region + Senior Manager, Risk Evaluation and Mitigation Strategies

Alexion/AstraZeneca Rare Disease

Serge Sagodira

Director Licensing Transactions

Debiopharm

Will DeLoache

Co-Founder & CEO

Novome Biotechnologies

Daniel van de Lelie

CEO

Gusto Global LLC

Kareem Barghouti

Co-Founder and CEO

Vast Biome

Paul Miller

CSO

Artizan Biosciences, Inc.

Ron Carter

CMO

Microbiotica

Afif Ghannoum

CEO

Biohm Health

Antonio Gomes

Principal Scientist

Xbiome

Daniel Couto

COO

Vedanta

Mark Carbonneau

Sr. Director, Head of Translational Science

Synlogictx

Taku Nakahara

Co-Founder & CEO

Metagen Therapeutics, Inc.

Tanya Yatsuneko

Chief Of Staff and head of Academic Collaborations

Bristol Myers Squibb

Wei-Kai Wu

Research Physician, Department of Medical Research, Division of Gastroenterology and Hepatology, Department of Internal Medicine

National Taiwan University Hospital, Department of Internal Medicine

Yoshinori Hamaji

Associate Scientific Director, Microbial Development

Takeda

Eran Kosover

Chief Business Officer

MyBiotics

James Mcllroy

CEO

Enterobiotix

Mary Ruisi

Vice President Clinical Research

Vedanta

Sophie Durand

CEO

Stellate Therapeutics

Bryan Jones

Senior Director, Scientific Affairs

Gelesis

Joe Trebley

CEO

Sciotio Biosciences

Magali Cordaillant-Simons

Scientific and Regulatory Affairs Director

PRI

Vivek Lal

Founder & CEO

Alveolus Bio & ResBiotic

Alessio Fando

Professor and Director of the Mucosal Immunology and Biology Research Center,

Massachusetts General Hospital

Christian Furlan Freguia

Vice President of Research

Rise Therapeutics

Elran Haber

CEO

Biomica Ltd.

Romain Daillere

Head of Preclinical Research & Co-founder

EverImmune

Elizabeth Halvorsen PhD

Director of Host Biology

Seres Therapeutics

Giulio Pasenetti

Saunders Family Chair and Professor of Neurology

Icahn School of Medicine at Mount Sinai

Lu Jing

Research Professional

University of Chicago Medicine

Nikhil Sharma

CEO

BioCorteX

Barbara McGovern MD

Senior Advisor Medical Affairs & Clinical Development

Seres Therapeutics

Christopher Ford

Exec. Director Microbiome Sciences

Seres Therapeutics

Jeffrey Heiser

Senior Director, Head of Process Development and Analytical Development

Arranta Bio

Shahram Lavasani

Founder & CEO

ImmuneBiotech AB

Amanda Prince

Senior Scientist, Immunology

Vedanta Biosciences, Inc.

Shuo Han

Postdoctoral Research Fellow in Microbiology and Immunology

Stanford University School of Medicine

Tue Hodal

Chief Manufacturing Officer

Bacthera

Yakov Ginzburg

R&D manager, Microbiome MetabolomicsTechnologies

Millipore Sigma

Bharat Dixit

VP, Biopharmaceutical Development & Manufacturing

Artugen Therapeutics

Maireadh Pedersen

CEO

SGS Quay Pharma

Nick Conley, PhD

VP of Technology

Locus Biosciences, Inc.

Stacy Burns-Guydish

President

List Labs

Brian Ingram

Director, Discovery & Translational Sciences

Metabolon

Johan Van Hylckama Vlieg

CSO

Kaleido Boiscience

Josh Narrow

Project Manager

The Conafay Group

Tina Papagiannopoulos

Associate

Foley Hoag-LLP

Eric Shaff

Chief Executive Officer

Seres Therapeutics

Matthew Henn PhD

Chief Scientific Officer

Seres Therapeutics

Natalie D’Amore PhD

Exec. Director External Innovation

Seres Therapeutics

Páraic Ó Cuív

Lead of Live Biotherapeutics

Microba

Cynthia L Sears MD

Cynthia L. Sears, M.D.

Professor of Medicine, Oncology and Molecular Microbiology and Immunology

Johns Hopkins University School of Medicine

George Weinstock, Ph.D.

George Weinstock, Ph. D.

Evnin Family Chair and Director, Microbial Genomics; Professor, Dept. Genetics and Genome Sciences

The Jackson Laboratory for Genomic Medicine; Univ. Connecticut Health Center

Manoj Dadlani

CEO

CosmosID, Inc.

Mo Langhi

Director, Business Development

CosmosID, Inc.

Dr Curtis Huttenhower

Curtis Huttenhower

Associate Professor

Harvard School of Public Health

Lutz Krause

Lutz Krause

Chief Scientific Officer

Microba Life Sciences